Buy & Sell Johnson & Johnson (JNJ) – Johnson & Johnson Price Today
Aura AI Summary
Key Stats
- $535.63BMarket Cap
- HealthSector
- -10.48%3M Drawdown
- $568.57BEnterprise Value
- 2.41%Dividend Yield
- 18% Buy | 82% SellTrading Activity
- 125 daysTypical Hold Time
Johnson & Johnson (JNJ) is currently valued at a market capitalization of $535.63B, with an enterprise value of $568.57B. Over the past 52 weeks, Johnson & Johnson has traded between a low of $146.36 and a high of $248.56, highlighting its annual price range. Over the past three months, Johnson & Johnson has recorded a drawdown of -10.48%, reflecting recent price volatility. Johnson & Johnson offers a dividend yield of 2.41%, with the most recent dividend of $1.30 paid on 24 Feb 26. On average, investors hold Johnson & Johnson for approximately 125 days, indicating typical investor behavior on the platform.
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Most Recent News
NuScale Power stock plunges 82%, but history shows strong recovery potential after big crashes.
NuScale Power's stock price fell sharply by 82%, marking a significant market crash for the company. Despite this steep decline, historical data suggests that companies experiencing similar crashes often recover strongly, with potential returns up to...
Law firm investigates Clearway Energy board for possible breach of duty
Kahn Swick & Foti, LLC has launched an investigation into Clearway Energy, Inc. for potential breach of fiduciary duty by its board of directors and controlling stockholder. The law firm is encouraging Clearway Energy shareholders to contact them to ...
Law firm investigates Scotts Miracle-Gro after sharp stock drop on poor financial results
Kahn Swick & Foti, LLC has launched an investigation into Scotts Miracle-Gro following the company's announcement of disappointing financial results in August 2023. Scotts reported a 6% decline in quarterly sales, a 420 basis point drop in gross marg...